Pharmafile Logo
Pharmafocus logo
Advanced Search

Nexavar

Showing 5 posts of 20 posts found.

NICE rejects Bayer’s liver cancer drug

May 26, 2010
Sales and Marketing NICE, Nexavar, patient access scheme

Bayer’s liver cancer drug Nexavar has been rejected by NICE after it deemed the drug too costly for a marginal …

News

Nexavar shows promise in breast cancer

September 24, 2009
Sales and Marketing Cancer, Nexavar, breast cancer

 Bayer’s Nexavar has been shown to significantly extend progression-free survival in patients with advanced breast cancer in a new phase …

News

NICE criticised for rejection of kidney cancer drugs

August 27, 2009
Research and Development, Sales and Marketing Kidney cancer, NICE, Nexavar

Three treatments for advanced kidney cancer have been rejected by NICE, sparking criticism from pharma companies and patient groups.The drugs …

News

NICE rejects Nexavar for liver cancer

May 7, 2009
Research and Development, Sales and Marketing Bayer, NICE, Nexavar

NICE has rejected Nexavar as a treatment for liver cancer, saying it is not a cost-effective use of NHS resources. …

News

Nexavar fails in melanoma study

April 30, 2009
Research and Development Bayer, Cancer, Nexavar

Onyx Pharmaceuticals and its development partner Bayer have stopped a phase II trial of Nexavar in patients with late-stage melanoma, …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024